![Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01868-6/MediaObjects/41416_2022_1868_Fig1_HTML.png)
Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer
![Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter](https://pbs.twimg.com/media/EmUwVZbXcAIaHnD.jpg)
Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter
![Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-72055-x/MediaObjects/41598_2020_72055_Fig1_HTML.png)
Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports
![Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer](https://www.mdpi.com/proteomes/proteomes-10-00013/article_deploy/html/images/proteomes-10-00013-g001.png)
Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
![First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/12/4417/F1.large.jpg)
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research
![Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer | World Journal of Surgical Oncology | Full Text Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-021-02448-3/MediaObjects/12957_2021_2448_Fig1_HTML.png)
Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer | World Journal of Surgical Oncology | Full Text
![Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65850-z/MediaObjects/41598_2020_65850_Fig1_HTML.png)
Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports
![Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-021-01802-5/MediaObjects/12935_2021_1802_Fig1_HTML.png)
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text
![Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26d9baf973907a54e3ab94697b7c0d6e648f2245/2-TableI-1.png)